… ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024 LEIDEN, Netherlands & … announced that the Company will host a virtual Analyst and Investor Event on Wednesday, December 11, 2024 from 10:00 am …
… MECP2 (R270X) for Rett Syndrome Hosting fall Analyst and Investor Event (virtual), featuring detailed AX-0810 Phase 1 … Axiomer pipeline and platform progress at our Analyst and Investor Event this fall.” Recent Progress In July, the … Upcoming Events ProQR will host a virtual Analyst and Investor Event in the fall to highlight a detailed overview …
Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase 1 study of AX-0810 in healthy volunteers, with initial safety, tolerability, and PK data from Cohort 1 expected by year-end, and target engagemen